Related Experiment Video
Updated: Aug 12, 2026

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
Published on: November 29, 2024
Elevated glycated haemoglobin in non-diabetic patients is associated with an increased mortality in myocardial
1Department of Medicine, Queen Elizabeth Hospital, Birmingham, UK.
Insights
Elevated glycated haemoglobin (HbA1c) levels are a significant risk factor for death after acute myocardial infarction, even in non-diabetic individuals. This finding highlights HbA1c as a crucial marker for short-term mortality risk.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Diabetes mellitus is linked to higher mortality rates post-acute myocardial infarction (AMI).
- Elevated glycated haemoglobin (HbA1c) in diabetic patients correlates with increased AMI mortality.
- Mild HbA1c elevations can indicate impaired glucose tolerance.
Purpose of the Study:
- To investigate the impact of HbA1c on AMI outcomes in non-diabetic patients.
- To identify HbA1c as a potential risk marker in this population.
Main Methods:
- Study included 253 non-diabetic patients experiencing AMI.
- Univariate and logistic regression analyses were performed.
- Risk factors for one-year mortality were assessed, including HbA1c, glucose, cholesterol, and smoking status.
Main Results:
- A total of 46 patients died within one year.
- Univariate analysis identified smoking, glucose, cholesterol, and HbA1c as risk factors for death.
- Logistic regression confirmed HbA1c as an independent risk factor for mortality.
- The highest HbA1c quartile was more prevalent in the non-surviving group (over one-third) compared to survivors (one-fifth).
Conclusions:
- Elevated HbA1c serves as a significant risk marker for short-term mortality following acute myocardial infarction in individuals without diabetes.
- HbA1c monitoring may be valuable for risk stratification in non-diabetic AMI patients.
Abstract:
Diabetes is associated with increased mortality following acute myocardial infarction compared to the general population. Elevated glycated haemoglobin (HbA1c) in diabetic patients is also associated with increased mortality following acute myocardial infarction, while mild elevation in HbA1c are associated with impaired glucose tolerance. The aim of this study was to determine the influence of HbA1c on outcome of acute myocardial infarction in 253 non-diabetic patients, 46 of whom died in one year. In univariate analysis, risk factors for death included smoking, glucose, cholesterol and HbA1c. In logistic regression analysis HbA1c was an independent risk factor for death. Over one-third of the fatality group had an HbA1c in the highest quartile, compared to one-fifth of the surviving group (p = 0.02). Elevated HbA1c is a risk marker for short-term mortality following acute myocardial infarction in non-diabetic subjects.
More Related Videos
09:35A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia
Published on: November 15, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Coronary Artery Disease I: Introduction
Hypoglycemia
Hyperglycemia
Diabetic Nephropathy